Study guide
Survivorship Palliative Psychosocial and Discharge Case Lab
OCN Oncology Certified Nurse Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: OCN Exam Orientation and Official Source Control
Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness
2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care
Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures
3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment
Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation
4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards
Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development
5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy
Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation
6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents
Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation
7 Chapter 7: Symptom Management and Supportive Care
Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination
8 Chapter 8: Oncologic Emergencies and Rapid Escalation
Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage
9 Chapter 9: Psychosocial Dimensions of Oncology Care
Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals
10 Chapter 10: Mixed OCN Case Labs
New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab
11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness
Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning
Survivorship Palliative Psychosocial and Discharge Case Lab
Key Takeaways Explain This Topic AI
Palliative care is appropriate at any stage alongside disease-directed therapy; hospice is a comfort-focused benefit for a prognosis of about 6 months or less when curative treatment is stopped.
Survivorship care plans include a treatment summary, surveillance schedule, late-effect monitoring (cardiotoxicity, neuropathy, secondary cancers), and who manages each issue.
Aromatase inhibitor adherence teaching covers arthralgia, hot flashes, and bone-density monitoring; the patient should not stop therapy independently for joint pain.
Use validated distress screening (NCCN Distress Thermometer); escalate suicidal ideation, abuse, severe depression, delirium, or caregiver collapse immediately.
A safe discharge confirms medications, opioid and bowel regimen teach-back, follow-up, equipment, caregiver capacity, and 24-hour emergency contacts.
Last updated: June 2026
- Case Lab: Survivorship, Palliative Care, Psychosocial Needs, and Discharge
- Case Snapshot
A 62-year-old completes chemotherapy for breast cancer and receives an aromatase inhibitor prescription, a surveillance plan, and a lymphedema-education referral. She reports fear of recurrence, hot flashes, joint pain, financial strain, and poor sleep. In the same clinic, a patient with progressive pancreatic cancer is discharged after pain control and biliary stent placement, with home palliative care and a possible later hospice discussion. These scenarios test transitions across the care continuum.
Survivorship Care
Survivorship begins at diagnosis, but the end-of-treatment visit is a key teaching and coordination moment. A survivorship care plan includes a diagnosis-and-treatment summary, surveillance schedule, late and long-term effects, health promotion, medication plan, genetic/family-risk follow-up, psychosocial resources, and a clear statement of which clinician manages each issue. The nurse reinforces the plan, checks understanding, and removes barriers.
- Need Nursing Assessment Education or Action
- Surveillance Knows follow-up schedule and symptoms to report Clarify appointments and urgent-contact triggers
Late effects Anthracycline cardiotoxicity, neuropathy, endocrine effects, secondary cancers Teach monitoring; refer (cardio-oncology, rehab)
Health promotion Smoking, activity, nutrition, vaccines, screening Reinforce evidence-based prevention within scope
Psychosocial Distress (NCCN Thermometer), fear, work, finances, sexuality, sleep Screen and refer (social work, financial navigation)
Medication safety Endocrine therapy, anticoagulants, analgesics, supplements Review adherence, adverse effects, interactions
The aromatase inhibitor patient needs teaching on adherence, arthralgia, hot flashes, and bone-density monitoring (AIs accelerate bone loss; DEXA surveillance and calcium/vitamin D per provider). Teach weight-bearing activity and reporting severe mood change, fractures, chest symptoms, or intolerable effects. Do not tell her to stop therapy independently for joint pain; assess severity and function, offer supportive strategies in scope, and notify the provider, who may switch agents or add management.
Palliative Care Is Not Giving Up
Palliative care focuses on quality of life, symptom control, communication, decision support, and caregiver support, and can run concurrently with chemotherapy, immunotherapy, radiation, surgery, or clinical trials. Hospice is a distinct benefit and philosophy for patients with a prognosis of about six months or less who choose comfort-focused care when disease-directed treatment is no longer beneficial or desired. The OCN exam tests this distinction directly: do not equate palliative care with stopping treatment.
For the pancreatic-cancer discharge, assess pain control, bowel regimen, nausea plan, nutrition, biliary stent symptoms (jaundice, fever, cholangitis triggers), medication access, caregiver ability, mobility, fall risk, advance care planning, and follow-up. Discharge teaching must include the exact medication schedule, breakthrough-pain instructions, constipation prevention with a scheduled stimulant laxative , who to call day or night, and when to seek urgent care. If the caregiver cannot safely manage medications or the patient cannot obtain opioids, discharge is not ready.
Psychosocial Dimensions and Discharge
Distress screening is not decoration. Cancer affects identity, roles, sexuality, fertility, finances, work, cognition, body image, culture, and spirituality. Use a validated tool such as the NCCN Distress Thermometer (0-10) ; a score of 4 or higher triggers referral per policy. Suicidal ideation, abuse, inability to obtain food or medication, severe depression, delirium, or caregiver collapse requires immediate escalation . Communicate directly: ask what the patient understands, what matters most, which symptoms are hardest, and who to include in decisions; use professional interpreters for clinical discussions.
A safe discharge confirms medications, equipment, home services, follow-up, transportation, labs, line/wound care, diet, activity, infection precautions, symptom action plans, and 24-hour emergency contacts. Use teach-back : have the patient or caregiver explain what they will do for fever, uncontrolled pain, vomiting, dyspnea, bleeding, confusion, or a medication problem. Reassessment continues after discharge through calls, portal review, home-care reports, and clinic visits.
The best OCN answer supports autonomy while protecting safety: clarify goals, manage symptoms, screen distress, coordinate resources, and ensure the patient knows what to do when the plan is not working.
Definitions, Documents, and Common Traps
The survivorship and end-of-life domain hinges on precise definitions. Palliative care is symptom- and quality-of-life-focused and runs alongside any treatment at any stage. Hospice is a comfort-focused benefit, generally for a prognosis of about six months or less if the disease runs its expected course, when curative treatment is stopped. The exam frequently offers "palliative care means giving up" or "hospice can be combined with chemotherapy" as distractors; both are wrong.
Documents and roles to keep straight:
An advance directive (living will) states a patient's wishes; a durable power of attorney for health care names a surrogate decision-maker; a POLST/MOLST is an actionable medical order set for the seriously ill.
A DNR order addresses resuscitation only; it does not stop other treatment or comfort care, a point the exam tests directly.
Anthracycline (doxorubicin) survivors need monitoring for late cardiotoxicity ; platinum and taxane survivors monitor for persistent peripheral neuropathy ; some chemo and radiation carry secondary-malignancy risk.
A score of 4 or higher on the NCCN Distress Thermometer triggers referral, and any suicidal statement is an immediate, non-negotiable escalation.
Distractors here include letting family wishes override a competent patient's voice, discharging when a caregiver fails teach-back on opioids, and treating distress screening as paperwork. The defensible answer respects autonomy, uses validated tools, confirms safe transitions with teach-back, and escalates psychosocial emergencies without delay.